These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 73517)

  • 21. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenic characteristics of Escherichia coli strains in cases of asymptomatic bacteriuria and symptomatic urinary tract infections].
    Misiewicz IA; Galiński J
    Med Dosw Mikrobiol; 1989; 41(3-4):151-9. PubMed ID: 2701235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.
    Ahlstedt S; Kaijser B
    Immunology; 1975 May; 28(5):841-6. PubMed ID: 1093966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection.
    Edén CS; Eriksson B; Hanson LA; Jodal U; Kaijser B; Janson GL; Lindberg U; Olling S
    J Pediatr; 1978 Sep; 93(3):398-403. PubMed ID: 357693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological response to P-fimbriae of Escherichia coli in patients with urinary tract infections.
    Agata N; Ohta M; Miyazawa H; Mori M; Kido N; Kato N
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):156-9. PubMed ID: 2566483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virulence factors of Escherichia coli. III. Correlation with Escherichia coli pathogenicity of haemolysin production, haemagglutinating capacity, antigens K1, K5, and colicinogenicity.
    Czirók E; Milch H; Csiszár K; Csik M
    Acta Microbiol Hung; 1986; 33(1):69-83. PubMed ID: 3529796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of immunization with K1-antigen of Escherichia coli on the course of experimental urinary tract infection in the rat].
    Straube E; Nimmich W; Broschewitz U; Naumann G
    Z Urol Nephrol; 1986 Jun; 79(6):335-46. PubMed ID: 3529745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum resistance in different serotypes of Escherichia coli.
    Falkenhagen U; Zingler G; Naumann G
    Zentralbl Bakteriol; 1991 Jun; 275(2):216-22. PubMed ID: 1718305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specificity of passive hemagglutination test in the serological diagnosis of urinary tract infections. I. Antibodies for homologous crude antigens in sera of children with pyelonephritis prior to and following absorption with E. coli 014 antigen].
    Wlodarczak K
    Med Dosw Mikrobiol; 1975; 27(1):31-6. PubMed ID: 1090792
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection.
    Kaijser B
    J Infect Dis; 1973 Jun; 127(6):670-7. PubMed ID: 4196446
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the antibody response to E. Coli O-antigens in children with urinary tract infections.
    Hassan AM; Sobhi FS; Eissa HA
    Gaz Egypt Paediatr Assoc; 1976; 24(3-4):169-75. PubMed ID: 801625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term study of humoral immune response in patients with chronic pyelonephritis.
    Nimmich W; Budde E; Naumann G; Klinkmann H
    Clin Nephrol; 1976 Oct; 6(4):428-32. PubMed ID: 788977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mannose-resistant hemagglutination and P receptor recognition of uropathogenic Escherichia coli isolated from adult patients.
    Gander RM; Thomas VL; Forland M
    J Infect Dis; 1985 Mar; 151(3):508-13. PubMed ID: 2857751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Defense mechanisms of the macro-organism in bacteriuria in chronic pyelonephritis].
    Falkenhagen U; Wendt M; Hilbert R; Zingler G
    Z Urol Nephrol; 1986 Nov; 79(11):619-27. PubMed ID: 3551386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic responses to heterologous escherichia serogroups in women with pyelonephritis.
    Carter MJ; Ehrenkranz NJ; Burns J; Cassady JC
    N Engl J Med; 1968 Dec; 279(26):1407-12. PubMed ID: 4881181
    [No Abstract]   [Full Text] [Related]  

  • 36. [Incidence of antibody-coated bacteria in patients with chronic pyelonephritis].
    Falkenhagen U; Hacker K; Rehbock A; Handschuck I; Nimmich W
    Z Urol Nephrol; 1986 Nov; 79(11):609-18. PubMed ID: 3551385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-dependent cell-mediated cytotoxicity against Escherichia coli O antigens.
    Hagberg M; Ahlstedt S; Hanson L
    Eur J Clin Microbiol; 1982 Feb; 1(1):59-65. PubMed ID: 6184220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibody titer in experimental urinary tract infection].
    Prát V; Konicková L; Ritzerfeld W; Losse H
    Zentralbl Bakteriol Orig; 1970; 212(2):512-4. PubMed ID: 4910456
    [No Abstract]   [Full Text] [Related]  

  • 39. An enzyme-linked immunosorbent assay for detection of antibodies against Escherichia coli: association between indirect hemagglutination test and survival.
    Leitner G; Melamed D; Drabkin N; Heller ED
    Avian Dis; 1990; 34(1):58-62. PubMed ID: 2181997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of preliminary sensitization and immunization on bacteriuria in rabbits with experimental pyelonephritis.
    Záruba K; Vejbora O; Chobola M
    Clin Exp Immunol; 1971 Sep; 9(3):399-405. PubMed ID: 4936874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.